Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Selkirk Neurology is a private U.S. neurology practice and comprehensive movement disorder center based in Spokane, Washington. The clinic focuses on diagnosis, longitudinal care, and supportive services for patients with Parkinson's disease, Huntington's disease, essential tremor, dystonia, multiple sclerosis, and other neurodegenerative and neuromuscular conditions. Its services include subspecialty movement-disorder care, infusion services, neurodiagnostics such as EMG/NCS and evoked potentials, botulinum toxin treatment, chronic care management, and use of tools such as genetic testing, imaging, wearable sensors, and neurostimulator implantation. The organization also participates in clinical research through a closely affiliated sister organization, Inland Northwest Research, but Selkirk Neurology itself appears to operate primarily as a patient-care provider rather than a drug-development biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Selkirk Neurology.